These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37138208)

  • 21. Spread of SARS-CoV-2 in the Icelandic Population.
    Gudbjartsson DF; Helgason A; Jonsson H; Magnusson OT; Melsted P; Norddahl GL; Saemundsdottir J; Sigurdsson A; Sulem P; Agustsdottir AB; Eiriksdottir B; Fridriksdottir R; Gardarsdottir EE; Georgsson G; Gretarsdottir OS; Gudmundsson KR; Gunnarsdottir TR; Gylfason A; Holm H; Jensson BO; Jonasdottir A; Jonsson F; Josefsdottir KS; Kristjansson T; Magnusdottir DN; le Roux L; Sigmundsdottir G; Sveinbjornsson G; Sveinsdottir KE; Sveinsdottir M; Thorarensen EA; Thorbjornsson B; Löve A; Masson G; Jonsdottir I; Möller AD; Gudnason T; Kristinsson KG; Thorsteinsdottir U; Stefansson K
    N Engl J Med; 2020 Jun; 382(24):2302-2315. PubMed ID: 32289214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Broad-based SARS-CoV-2 testing program for healthcare workers in a primary care hospital in France.
    Chas J; Nadal M; Siguier M; Fajac A; Denis M; Morand-Joubert L; Pialoux G
    Infect Dis Now; 2021 Sep; 51(6):556-559. PubMed ID: 34000458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of SARS-CoV-2 among homeless people, asylum-seekers and other people living in precarious conditions in Marseille, France, March-April 2020.
    Ly TDA; Nguyen NN; Hoang VT; Goumballa N; Louni M; Canard N; Dao TL; Medkour H; Borg A; Bardy K; Esteves-Vieira V; Filosa V; Davoust B; Mediannikov O; Fournier PE; Raoult D; Gautret P
    Int J Infect Dis; 2021 Apr; 105():1-6. PubMed ID: 33578010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.
    Robineau O; Zins M; Touvier M; Wiernik E; Lemogne C; de Lamballerie X; Blanché H; Deleuze JF; Saba Villarroel PM; Dorival C; Nicol J; Gomes-Rima R; Correia E; Coeuret-Pellicer M; Druesne-Pecollo N; Esseddik Y; Ribet C; Goldberg M; Severi G; Carrat F;
    JAMA Netw Open; 2022 Nov; 5(11):e2240985. PubMed ID: 36350653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.
    Bajema KL; Wiegand RE; Cuffe K; Patel SV; Iachan R; Lim T; Lee A; Moyse D; Havers FP; Harding L; Fry AM; Hall AJ; Martin K; Biel M; Deng Y; Meyer WA; Mathur M; Kyle T; Gundlapalli AV; Thornburg NJ; Petersen LR; Edens C
    JAMA Intern Med; 2021 Apr; 181(4):450-460. PubMed ID: 33231628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 self-test uptake and factors associated with self-testing during Omicron BA.1 and BA.2 waves in France, January to May 2022.
    Supplisson O; Charmet T; Galmiche S; Schaeffer L; Chény O; Lévy A; Jeandet N; Omar F; David C; Mailles A; Fontanet A
    Euro Surveill; 2023 May; 28(18):. PubMed ID: 37140451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community-Based Testing Sites for SARS-CoV-2 - United States, March 2020-November 2021.
    Miller MF; Shi M; Motsinger-Reif A; Weinberg CR; Miller JD; Nichols E
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1706-1711. PubMed ID: 34882655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
    Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experiences and needs of persons living with a household member infected with SARS-CoV-2: A mixed method study.
    Verberk JDM; Anthierens SA; Tonkin-Crine S; Goossens H; Kinsman J; de Hoog MLA; Bielicki JA; Bruijning-Verhagen PCJL; Gobat NH
    PLoS One; 2021; 16(3):e0249391. PubMed ID: 33788890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020.
    Biggs HM; Harris JB; Breakwell L; Dahlgren FS; Abedi GR; Szablewski CM; Drobeniuc J; Bustamante ND; Almendares O; Schnall AH; Gilani Z; Smith T; Gieraltowski L; Johnson JA; Bajema KL; McDavid K; Schafer IJ; Sullivan V; Punkova L; Tejada-Strop A; Amiling R; Mattison CP; Cortese MM; Ford SE; Paxton LA; Drenzek C; Tate JE;
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):965-970. PubMed ID: 32701941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.
    Wohl DA; Barzin AH; Napravnik S; Davy-Mendez T; Smedberg JR; Thompson CM; Ruegsegger L; Gilleskie M; Weber DJ; Whinna HC; Miller MB
    PLoS One; 2021; 16(12):e0260879. PubMed ID: 34890441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study.
    Landoas A; Cazzorla F; Gallouche M; Larrat S; Nemoz B; Giner C; Le Maréchal M; Pavese P; Epaulard O; Morand P; Mallaret MR; Landelle C
    Antimicrob Resist Infect Control; 2021 Aug; 10(1):114. PubMed ID: 34353356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
    He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C
    Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area.
    Meyers KJ; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
    J Med Virol; 2020 Nov; 92(11):2874-2879. PubMed ID: 32543722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020-a cross-sectional study.
    Maechler F; Gertler M; Hermes J; van Loon W; Schwab F; Piening B; Rojansky S; Hommes F; Kausch F; Lindner AK; Burock S; Rössig H; Hartmann C; Kirchberger V; Thieme A; Behnke M; Gastmeier P; Mockenhaupt FP; Seybold J
    Clin Microbiol Infect; 2020 Dec; 26(12):1685.e7-1685.e12. PubMed ID: 32827715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study.
    Meyers KJ; Dillman B; Williams C; Jiang J; Clifford N; Miller JL; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
    J Med Virol; 2021 May; 93(5):2925-2931. PubMed ID: 33463731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.